179 related articles for article (PubMed ID: 27446211)
1. Clinical Performance and Management Outcomes with the DecisionDx-UM Gene Expression Profile Test in a Prospective Multicenter Study.
Plasseraud KM; Cook RW; Tsai T; Shildkrot Y; Middlebrook B; Maetzold D; Wilkinson J; Stone J; Johnson C; Oelschlager K; Aaberg TM
J Oncol; 2016; 2016():5325762. PubMed ID: 27446211
[TBL] [Abstract][Full Text] [Related]
2. Prospective evaluation of risk-appropriate management of uveal melanoma patients informed by gene expression profiling.
Schefler AC; Skalet A; Oliver SC; Mason J; Daniels AB; Alsina KM; Plasseraud KM; Monzon FA; Firestone B
Melanoma Manag; 2020 Mar; 7(1):MMT37. PubMed ID: 32399175
[TBL] [Abstract][Full Text] [Related]
3. The DecisionDx-UM Gene Expression Profile Test Provides Risk Stratification and Individualized Patient Care in Uveal Melanoma.
Harbour JW; Chen R
PLoS Curr; 2013 Apr; 5():. PubMed ID: 23591547
[TBL] [Abstract][Full Text] [Related]
4. Current clinical practice: differential management of uveal melanoma in the era of molecular tumor analyses.
Aaberg TM; Cook RW; Oelschlager K; Maetzold D; Rao PK; Mason JO
Clin Ophthalmol; 2014; 8():2449-60. PubMed ID: 25587217
[TBL] [Abstract][Full Text] [Related]
5. Clinical impact of a 31-gene expression profile test for cutaneous melanoma in 156 prospectively and consecutively tested patients.
Berger AC; Davidson RS; Poitras JK; Chabra I; Hope R; Brackeen A; Johnson CE; Maetzold DJ; Middlebrook B; Oelschlager KM; Cook RW; Monzon FA; Miller AR
Curr Med Res Opin; 2016 Sep; 32(9):1599-604. PubMed ID: 27210115
[TBL] [Abstract][Full Text] [Related]
6. Gene Expression Profiling in Uveal Melanoma: Five-Year Prospective Outcomes and Meta-Analysis.
Aaberg TM; Covington KR; Tsai T; Shildkrot Y; Plasseraud KM; Alsina KM; Oelschlager KM; Monzon FA
Ocul Oncol Pathol; 2020 Oct; 6(5):360-367. PubMed ID: 33123530
[TBL] [Abstract][Full Text] [Related]
7. Analytical validity of DecisionDx-SCC, a gene expression profile test to identify risk of metastasis in cutaneous squamous cell carcinoma (SCC) patients.
Borman S; Wilkinson J; Meldi-Sholl L; Johnson C; Carter K; Covington KR; Fitzgerald AL; Kurley SJ; Farberg AS; Goldberg MS; Monzon FA; Oelschlager K; Cook RW
Diagn Pathol; 2022 Feb; 17(1):32. PubMed ID: 35216597
[TBL] [Abstract][Full Text] [Related]
8. Interim analysis of survival in a prospective, multi-center registry cohort of cutaneous melanoma tested with a prognostic 31-gene expression profile test.
Hsueh EC; DeBloom JR; Lee J; Sussman JJ; Covington KR; Middlebrook B; Johnson C; Cook RW; Slingluff CL; McMasters KM
J Hematol Oncol; 2017 Aug; 10(1):152. PubMed ID: 28851416
[TBL] [Abstract][Full Text] [Related]
9. A prognostic test to predict the risk of metastasis in uveal melanoma based on a 15-gene expression profile.
Harbour JW
Methods Mol Biol; 2014; 1102():427-40. PubMed ID: 24258991
[TBL] [Abstract][Full Text] [Related]
10. Analytic validity of DecisionDx-Melanoma, a gene expression profile test for determining metastatic risk in melanoma patients.
Cook RW; Middlebrook B; Wilkinson J; Covington KR; Oelschlager K; Monzon FA; Stone JF
Diagn Pathol; 2018 Feb; 13(1):13. PubMed ID: 29433548
[TBL] [Abstract][Full Text] [Related]
11. Prognostic Implications of Tumor Diameter in Association With Gene Expression Profile for Uveal Melanoma.
Walter SD; Chao DL; Feuer W; Schiffman J; Char DH; Harbour JW
JAMA Ophthalmol; 2016 Jul; 134(7):734-40. PubMed ID: 27123792
[TBL] [Abstract][Full Text] [Related]
12. Collaborative Ocular Oncology Group report number 1: prospective validation of a multi-gene prognostic assay in uveal melanoma.
Onken MD; Worley LA; Char DH; Augsburger JJ; Correa ZM; Nudleman E; Aaberg TM; Altaweel MM; Bardenstein DS; Finger PT; Gallie BL; Harocopos GJ; Hovland PG; McGowan HD; Milman T; Mruthyunjaya P; Simpson ER; Smith ME; Wilson DJ; Wirostko WJ; Harbour JW
Ophthalmology; 2012 Aug; 119(8):1596-603. PubMed ID: 22521086
[TBL] [Abstract][Full Text] [Related]
13. Variable Results for Uveal Melanoma-Specific Gene Expression Profile Prognostic Test in Choroidal Metastasis.
Klufas MA; Itty S; McCannel CA; Glasgow BJ; Moreno C; McCannel TA
JAMA Ophthalmol; 2015 Sep; 133(9):1073-6. PubMed ID: 26086628
[TBL] [Abstract][Full Text] [Related]
14. PRAME as a Potential Target for Immunotherapy in Metastatic Uveal Melanoma.
Gezgin G; Luk SJ; Cao J; Dogrusöz M; van der Steen DM; Hagedoorn RS; Krijgsman D; van der Velden PA; Field MG; Luyten GPM; Szuhai K; Harbour JW; Jordanova ES; Heemskerk MHM; Jager MJ
JAMA Ophthalmol; 2017 Jun; 135(6):541-549. PubMed ID: 28448663
[TBL] [Abstract][Full Text] [Related]
15. Relationship between clinical features, GEP class, and PRAME expression in uveal melanoma.
Schefler AC; Koca E; Bernicker EH; Correa ZM
Graefes Arch Clin Exp Ophthalmol; 2019 Jul; 257(7):1541-1545. PubMed ID: 31065847
[TBL] [Abstract][Full Text] [Related]
16. Uveal melanoma gene expression profile test result provided for uveal metastasis.
Seider MI; Stewart PJ; Mishra KK; Damato BE
Ophthalmic Surg Lasers Imaging Retina; 2014; 45(5):441-2. PubMed ID: 25153656
[TBL] [Abstract][Full Text] [Related]
17. Characterizing metastatic uveal melanoma patients who develop symptomatic brain metastases.
Wei AZ; Uriel M; Porcu A; Manos MP; Mercurio AC; Caplan MM; Hulse L; Seedor RS; Holovatska M; Francis J; Khan SA; McDonnell DE; Bogomolny D; Sato T; Marr BP; Haq R; Orloff M; Shoushtari A; Carvajal RD
Front Oncol; 2022; 12():961517. PubMed ID: 36212499
[TBL] [Abstract][Full Text] [Related]
18. Uveal Melanoma with Histopathologic Intratumoral Heterogeneity Associated with Gene Expression Profile Discordance.
Miller AK; Benage MJ; Wilson DJ; Skalet AH
Ocul Oncol Pathol; 2017 Jul; 3(2):156-160. PubMed ID: 28868288
[TBL] [Abstract][Full Text] [Related]
19. PRAME as an Independent Biomarker for Metastasis in Uveal Melanoma.
Field MG; Decatur CL; Kurtenbach S; Gezgin G; van der Velden PA; Jager MJ; Kozak KN; Harbour JW
Clin Cancer Res; 2016 Mar; 22(5):1234-42. PubMed ID: 26933176
[TBL] [Abstract][Full Text] [Related]
20. Gene expression profiling in uveal melanoma: technical reliability and correlation of molecular class with pathologic characteristics.
Plasseraud KM; Wilkinson JK; Oelschlager KM; Poteet TM; Cook RW; Stone JF; Monzon FA
Diagn Pathol; 2017 Aug; 12(1):59. PubMed ID: 28778171
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
